Proxy Votes Now

Home › Funds › New York Life › NYLI Global Equity R&D Leaders ETF

NYLI Global Equity R&D Leaders ETF (WRND) proxy voting record 2025-2026

Fund family: New York Life · Filed by New York Life Investments ETF Trust (CIK 1415995) · SEC series S000074744

Ticker: WRND (C000232897)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,586 with, 94 against, 4 abstentions (not counted as with management); 13 items carried no recommendation; 3 split votes are in neither count. Shareholder proposals: 32 FOR, 66 AGAINST, 6 abstained, by the filing’s own vote-source field.

Compared with New York Life as a whole

The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsNew York LifeItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.8%2,08792.5%47,807
Backed environmental and social shareholder proposals at US companiesn/a4714.2%772

Where this fund voted differently from most New York Life funds

Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most New York Life funds on 8 items (0.9% of the 939 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost New York Life fundsMgmtResult
Oracle Corporation2025-11-18Election of Directors: Awo AbloWithholdFOR — 5 of 7 New York Life fundsAgainstElected, 83.9% support
Oracle Corporation2025-11-18Election of Directors: Bruce R. ChizenWithholdFOR — 5 of 7 New York Life fundsAgainstElected, 76.1% support
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersAgainstFOR — 5 of 8 New York Life fundsAgainstPassed (calculated), 81.9% support
Novo Nordisk A/S2025-11-14Shareholder Elect Britt Meelby Jensen as New DirectorAbstainFOR — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Cees de Jong (Vice Chair) as New DirectorAbstainFOR — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Lars Rebien Sorensen (Chair) as New DirectorAbstainFOR — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Mikael Dolsten as New DirectorAbstainFOR — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Stephan Engels as New DirectorAbstainFOR — 2 of 3 New York Life funds——

Download all 8 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,3731
Corporate Governance51229
Capital Structure2513
Compensation2386
Audit-related1590
Say-on-Pay780
Other Social Issues3223
Environment or Climate2020
Extraordinary Transactions170
Other110

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Meta Platforms, Inc.May 27, 2026$677,776228
Apple Inc.February 24, 2026$645,587121
NVIDIA CorporationJune 24, 2026$616,909164
Alphabet Inc.June 5, 2026$587,0172310
Microsoft CorporationDecember 5, 2025$542,854216
Amazon.com, Inc.May 20, 2026$483,281174
Broadcom Inc.April 20, 2026$314,730100
Eli Lilly and CompanyMay 4, 2026$302,479102

Notable votes against management

MeetingCompanyProposalFundMgmt
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding dual class capital structure. Shareholder proposalForAgainst
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst

Search this fund’s votes by company

2,708 ballot items at 210 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, NYLI Global Equity R&D Leaders ETF (WRND) voted at 210 shareholder meetings of 199 companies, on 2,708 ballot items in all. Where management made a recommendation, the fund followed it on 96.3% of the items and voted against it 94 times. Its most frequent area of disagreement was corporate governance (29 of its votes against management). It voted FOR 32.7% of the 98 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than New York Life's funds as a whole (91.8% against 92.5%). It voted differently from most New York Life funds on 8 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.